Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors

Annals of Oncology

Volumn 12, Issue 11, 2001, Pages 1643-1649

  Marty, M ^a   Fumoleau, P ^b   Adenis, A ^c   Rousseau, Y ^d   Merrouche, Y ^e   Robinet, G ^d   Senac, I ^f   Puozzo, C ^f  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE RENÉ GAUDUCHEAU   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d Groupe Hospitalier René Dubos   (France)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^f INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Bioavailability; bioequivalence; Pharmacokinetics; Pharmacokinetics pharmacodynamics; Vinca alkaloid

Indexed keywords

GELATIN; NAVELBINE; SCHERER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG EXPOSURE; DRUG FORMULATION; DRUG SAFETY; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEUTROPENIA; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; URINALYSIS;

EID: 0035686492     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013180903805     Document Type: Article

References (16)

1. The synthesis of navelbine prototype of a new series of vinblastine derivatives
2. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors
3. 3] navelbine in patients: Comparative pharmacokinetics using radioactive and radioimmunologic determination methods
4. Patients preferences for oral vs. intravenous palliative chemotherapy
5. Oral chemotherapy: Rationale and future directions
6. Individual variation in first-pass metabolism
7. Vinorelbine: A horse of a different color?
8. Phase I trial of escalating doses of orally administered navelbine. Part II - Clinical results
9. Phase I trial of escalating doses of orally administered navelbine. Part I - Pharmacokinetics
10. Comparative pharmacokinetics of antitumor vinca alkaloids: Intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats
11. Relative bioavailability of two oral formulations of navelbine in cancer patients
12. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel
13. The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel
14. P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs
15. Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients